Despite being of similar age at study entry, LRRK2 G2019S carriers reported their age of PD diagnosis 1.9 years younger [standard error (SE) = 0.7 years; P = 0.027] than non-carriers, resulting in a longer disease duration at the time of entry. Here, LRRK2 is linked to Parkinson disease.